Cyclosporine ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca.
Review the October 2021 notable drug approvals.
Tyrvaya contains varenicline, a highly selective nicotinic acetylcholine agonist.
This week: The FDA authorize boosters for Moderna and Janssen and okay ‘mixing and matching’ of vaccines for the booster dose. The first interchangeable biosimilar to Humira is approved. Also there’s approvals in dry eye disease, pain management and opioid overdoses.
Tyrvaya contains varenicline, a highly selective nicotinic acetylcholine agonist.
The over-the-counter product may be used as a protectant against further eye irritation and to relieve dryness of the eye.
The investigational nasal spray contains varenicline, a highly selective nicotinic acetylcholine agonist.
Refresh Digital is designed to protect tears from evaporating due to incomplete blinking during digital device use.
Eysuvis (loteprednol etabonate ophthalmic suspension) is now available for the short-term treatment of the signs and symptoms of dry eye disease.
This week we cover a study that identified factors associated with strong antibody responses to COVID; How convalescent plasmas benefits may be limited; A nasal spray to treat diabetic gastroparesis; Recommendations for colorectal cancer screening; And a new treatment approved for dry eye disease. And of course, movie trivia!
